•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Rocket Lab has climbed from around $21 per share to more than $73 over the past year, representing just shy of a 250% increase. The key question for investors is whether the company’s momentum warrants a long-term position.
Rocket Lab posted record revenue of $602 million in 2025, up 38% year over year. Its backlog rose 73% to nearly $1.9 billion, signaling continued demand for its services.
The company executed 21 missions last year with a 100% success rate. That performance helped it secure an $816 million contract from the Space Development Agency. Rocket Lab’s space systems segment—covering satellites and other spacecraft—now accounts for roughly 67% of revenue, reinforcing its positioning as an end-to-end space company.
Rocket Lab’s most important growth driver has yet to reach the market. Its upcoming medium-lift rocket, Neutron, is expected to enable direct competition with SpaceX’s Falcon 9. The article states Neutron’s price point works out to roughly $15 million less per launch.
Despite the growth, the stock run-up has pushed valuation higher. Shares are trading at about 66 times sales, which the article describes as expensive—particularly because Rocket Lab is still operating in the red.
The company lost nearly $200 million on $602 million in sales. While the article notes margins are improving, profitability remains a key concern.
The article highlights that space flight carries significant uncertainty. If Neutron’s launch is delayed further—or if the rocket proves less reliable than expected—Rocket Lab could face serious challenges. In that scenario, the $1.9 billion backlog might not convert into realized revenue.
The article argues that much of the future success appears to be priced in. It also points to the broader opportunity: SpaceX is planning an IPO at a valuation of roughly $2 trillion, and Rocket Lab’s market capitalization is cited at about $40 billion.
Bottom line: Rocket Lab is described as a well-run company in an expanding market with meaningful opportunities ahead. However, whether it fits a “buy-and-never-sell” approach depends on risk tolerance. The article concludes that for many investors, the premium valuation and execution risk make the stock too risky and too expensive to become a large portfolio position.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
